398 related articles for article (PubMed ID: 23621533)
1. Targeted drug delivery across the blood brain barrier in Alzheimer's disease.
Rocha S
Curr Pharm Des; 2013; 19(37):6635-46. PubMed ID: 23621533
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
Banks WA
Adv Drug Deliv Rev; 2012 May; 64(7):629-39. PubMed ID: 22202501
[TBL] [Abstract][Full Text] [Related]
4. Targeted Nanoparticles for the Treatment of Alzheimer's Disease.
MartÃn-Rapun R; De Matteis L; Ambrosone A; Garcia-Embid S; Gutierrez L; de la Fuente JM
Curr Pharm Des; 2017; 23(13):1927-1952. PubMed ID: 28025949
[TBL] [Abstract][Full Text] [Related]
5. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
[TBL] [Abstract][Full Text] [Related]
6. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
7. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease drug development and the problem of the blood-brain barrier.
Pardridge WM
Alzheimers Dement; 2009 Sep; 5(5):427-32. PubMed ID: 19751922
[TBL] [Abstract][Full Text] [Related]
9. The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview.
Jakki SL; Senthil V; Yasam VR; Chandrasekar MJN; Vijayaraghavan C
Curr Drug Targets; 2018; 19(2):155-169. PubMed ID: 28606049
[TBL] [Abstract][Full Text] [Related]
10. Getting into the brain: approaches to enhance brain drug delivery.
Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
[TBL] [Abstract][Full Text] [Related]
11. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
[TBL] [Abstract][Full Text] [Related]
12. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
13. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
Sharma HS; Castellani RJ; Smith MA; Sharma A
Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
[TBL] [Abstract][Full Text] [Related]
14. Developing Trojan horses to induce, diagnose and suppress Alzheimer's pathology.
Aziz AA; Amtul Z
Pharmacol Res; 2019 Nov; 149():104471. PubMed ID: 31590012
[TBL] [Abstract][Full Text] [Related]
15. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease and drug delivery across the blood-brain barrier: approaches and challenges.
Iqbal I; Saqib F; Mubarak Z; Latif MF; Wahid M; Nasir B; Shahzad H; Sharifi-Rad J; Mubarak MS
Eur J Med Res; 2024 Jun; 29(1):313. PubMed ID: 38849950
[TBL] [Abstract][Full Text] [Related]
17. Transport of drugs across the blood-brain barrier by nanoparticles.
Wohlfart S; Gelperina S; Kreuter J
J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
[TBL] [Abstract][Full Text] [Related]
18. In vivo Evaluation and Alzheimer's Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System.
Zhang C; Gu Z; Shen L; Liu X; Lin H
Curr Pharm Biotechnol; 2019; 20(1):56-62. PubMed ID: 30727887
[TBL] [Abstract][Full Text] [Related]
19. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
Gaillard PJ; de Boer AG
Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
[TBL] [Abstract][Full Text] [Related]
20. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
